Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul 1;107(7):e188-e189.
doi: 10.1097/TP.0000000000004628. Epub 2023 May 12.

Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients

Juan Manuel Cazorla  1 , Florentino Villanego  1 , Aurora Aguilera  1 , Teresa Garcia  1 , Cristhian Orellana  1 , Teresa Trujillo  2 , Ana María Gómez  1 , Auxiliadora Mazuecos  1
Affiliations
Comment

Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients

Juan Manuel Cazorla et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Comment in

Comment on

References

    1. Hod T, Ben-David A, Olmer L, et al. Humoral response of renal transplant recipients to the BNT162b2 SARS-CoV-2 mRNA vaccine using both RBD IgG and neutralizing antibodies. Transplantation. 2021;105:e234–e243.
    1. Ministry of Health. Government of Spain. Update of vaccination recommendatios against covid-19 for autumn-winter in Spain. Available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacu... . 2022. Accessed January 30, 2023.
    1. Abedon AT, Teles MS, Alejo JL, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation. 2022;106:e262–e263.
    1. Osmanodja B, Ronicke S, Budde K, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med. 2022;11:2565.
    1. Imai M, Ito M, Kiso M, et al. Efficacy of antiviral agents against Omicron subvariants BQ.1.1 and XBB. N Engl J Med. 2023;388:89–91.